Active surveillance could help lead to early excision of melanoma, and thus better outcomes, in patients with CLL.
A study on pheochromocytoma and paraganglioma associated with neurofibromatosis type 1 highlights how screening for these malignancies is important.
Sorafenib combined with topotecan and then continued as maintenance therapy offered a significant improvement in survival outcomes in women with platinum-resistant ovarian cancer.
Researchers have developed a clinical prediction model for the metastatic potential of pheochromocytoma and paraganglioma.
Apatinib combined with etoposide offers promising efficacy in patients with platinum-resistant ovarian cancer.
Baseline levels of lactate dehydrogenase are significantly associated with progression-free survival outcomes in patients with BRAF V600–mutated metastatic melanoma.
A study using multigene panel testing identified several pathogenic variants associated with an increased risk of triple-negative breast cancer.
A meta-analysis identified several factors that are correlated with locoregional recurrence in patients with nonmetastatic muscle-invasive bladder cancer.
Low-dose CT screening for lung cancer is recommended for certain individuals, but two new studies highlight some of the limitations and growing pains of a screening program.
The presence of HER3 expression and a high HER2/CEP17 ratio distinguish a group of invasive HER2-positive ductal breast cancer patients who have a worse prognosis.